Corrigendum: Time to clinical improvement: an appropriate surrogate endpoint for pulmonary arterial hypertension medication trials

A Corrigendum on Time to clinical improvement: an appropriate surrogate endpoint for pulmonary arterial hypertension medication trials By Wang A, Chen M, Zhuang Q, Guan L, Xie W, Wang L, Huang W, Cheng Z, Yu S, Zhou H, Shen J. (2023). Front Cardiovasc Med. 10:1142721. doi: 10.3389/fcvm.2023.1142721

Incorrect Funding

In the published article, there was an error in the Funding statement.

There was an error in specifying the grant number of National Natural Science Foundation of China (CN) in the Funding section of the paper. The correct grant number is [81970047] and [82270050], but it was mistakenly written as [81800047].

The original text was: This work was supported by the National Natural Science Foundation of China (CN) (81800047) and the Clinical Research Innovation and Incubation Foundation of Renji Hospital, Shanghai Jiao Tong University School of Medicine (PYII20-13).

The correct Funding statement appears below.

Funding Statement

This work was supported by the National Natural Science Foundation of China (CN) (81970047, 82270050) and the Clinical Research Innovation and Incubation Foundation of Renji Hospital, Shanghai Jiao Tong University School of Medicine (PYII20-13).

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.